Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Transurethral resection is a less invasive type of surgery for bladder cancer and
may have fewer side effects and improve recovery. Drugs used in chemotherapy use different
ways to stop tumor cells from dividing so they stop growing or die. It is not yet known
whether transurethral resection plus AD 32 is more effective than transurethral resection
alone for bladder cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of transurethral resection
surgery followed by AD 32 with that of transurethral resection alone in treating patients who
have newly diagnosed or recurrent bladder cancer.